国家药品集中采购对肺癌住院患者健康支出的影响数据集
基于某大型三甲医院肺癌住院患者数据，采用差分差分法分析国家集中采购政策对健康支出的影响，发现政策降低了总支出和药品支出。
基本信息
资源简介
国家药品集中采购对肺癌住院患者健康支出的影响数据集
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 1.03 MB，主题涵盖 cancer、drug policy、evidence-based policy、health economics、policy evaluation，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Data_Sheet_1_The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China.docx》。配套论文《Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis》发表于 BMC Public Health（2021），DOI：10.1186/s12889-021-11882-7。源站首次发布：2022-08-12。
【数据内容】
源站原始描述：The availability and affordability of medicines remain major health challenges around the world. In March 2019, the Chinese government introduced a pilot National Centralized Drug Procurement (NCDP) program in order to reduce drug prices and improve the affordability of effective and safe medicines. This study aimed to assess the impact of NCDP policy on health expenditures of cancer patients. Using inpatient discharge records from a large hospital in the pilot city, we performed a difference-in…
中文译文（机器翻译，仅供快速理解，请以原文为准）：药物的可及性和可负担性仍然是全球主要的健康挑战。2019年3月，中国政府推出了国家集中药品采购（NCDP）试点项目，以降低药品价格并提高有效且安全药物的可负担性。本研究旨在评估NCDP政策对癌症患者医疗支出的影响。利用试点城市一家大型医院的住院出院记录，我们采用双重差分设计来估计政策实施前后医疗支出的变化。我们发现，NCDP的实施与每次住院总支出（14.13%）和药品支出（20.75%）的显著下降相关。非药品相关支出也显著降低，包括每次住院的医疗服务支出下降7.65%、诊断支出下降38.28%、耗材支出下降25.31%。然而，NCDP的实施与中医药支出增加107.97%相关。总体而言，该研究提供了证据，表明NCDP政策实现了高质量且可负担的医疗保健目标。肺癌患者的药品支出呈持续下降趋势，且该政策可能对其他医疗保健支出产生溢出效应。需要进一步研究来评估NCDP对政策相关支出和健康结局的长期影响。
【数据结构与技术规格】
文件数 1 个，合计 1.03 MB。Data_Sheet_1_The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analys.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，1.03 MB。数据集 DOI：10.3389/fpubh.2022.956823.s001。
【主题与分类】
源站学科分类：Aboriginal and Torres Strait Islander Health、Aged Health Care、Care for Disabled、Community Child Health、Environmental and Occupational Health and Safety、Epidemiology。主题标签：cancer、drug policy、evidence-based policy、health economics、policy evaluation。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_The_impact_of_national_centralized_drug_procurement_on_health_expenditures_for_lung_cancer_inpatients_A_difference-in-differences_analysis_in_a_large_tertiary_hospital_in_China_docx/20478858
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Zhang, Yuan-jin; Ren, Yan; Zheng, Quan; Tan, Jing; Yao, Ming-hong; Huang, Yun-xiang; et al. (2022). Data_Sheet_1_The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China.docx. Fro…
【使用注意】
· 源站最后修改于 2023-06-02，引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Data_Sheet_1_The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China.docx
- DOI：10.3389/fpubh.2022.956823.s001
- 发布日期：2022-08-12
- 文件数：1 个
- 文件总体积：1.03 MB
- 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_The_impact_of_national_centralized_drug_procurement_on_health_expenditures_for_lung_cancer_inpatients_A_difference-in-differences_analysis_in_a_large_tertiary_hospital_in_China_docx/20478858
命令行下载
curl -L -o "Data_Sheet_1_The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analys.docx" "https://ndownloader.figshare.com/files/36651645"
文件清单
Data_Sheet_1_The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analys.docx（1.03 MB）
文件总体积 1.03 MB（源站 API 实测）。
数据加载示例（图像类）
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
The availability and affordability of medicines remain major health challenges around the world. In March 2019, the Chinese government introduced a pilot National Centralized Drug Procurement (NCDP) program in order to reduce drug prices and improve the affordability of effective and safe medicines. This study aimed to assess the impact of NCDP policy on health expenditures of cancer patients. Using inpatient discharge records from a large hospital in the pilot city, we performed a difference-in-differences design to estimate the change in health expenditures before and after the policy. We found that the implementation of NCDP was associated with a significant decrease in total expenditures (14.13%) and drug expenditures (20.75%) per inpatient admission. There were also significant reductions in non-drug-related expenditures, including a 7.65% decrease in health service expenditures, a 38.28% decrease in diagnosis expenditures, and a 25.31% decrease in consumable material expenditures per inpatient admission. However, the NCDP implementation was associated with a 107.97% increase in the traditional Chinese medicine expenditures. Overall, the study provided evidence that the NCDP policy has achieved its goals of high-quality and affordable healthcare. The drug expenditures of lung cancer patients revealed a continuous decline, and the policy may have spillover effects on other healthcare expenditures. Further studies are needed to evaluate the long-term effects of NCDP on policy-related expenditures and health outcomes.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fpubh.2022.956823.s001（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_The_impact_of_national_centralized_drug_procurement_on_health_expenditures_for_lung_cancer_inpatients_A_difference-in-differences_analysis_in_a_large_tertiary_hospital_in_China_docx/20478858）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
